A COVID-19 vaccine developed jointly by a Taiwanese biomedical company and the United States National Institutes of Health (NIH) has been given conditional approval to enter human trials, Taiwan's Food and Drug Administration (FDA) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Mandated home visits for registered private nannies to increase: Ministry
04/25/2024 09:13 PM - Business
Taipower grid resilience plan to give science parks direct power supply
04/25/2024 08:58 PM - Business
President Tsai lauds inauguration of Changhua offshore wind farms
04/25/2024 08:38 PM - Society
Number of black-faced spoonbills in Taiwan falls for first time
04/25/2024 07:32 PM - Cross-Strait
New MAC head signals Lai's wish for stable cross-strait ties: Analysts
04/25/2024 07:06 PM